{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:23:57Z","timestamp":1793089437788,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002631","name":"Gachon University","doi-asserted-by":"publisher","award":["GCU-202300610001"],"award-info":[{"award-number":["GCU-202300610001"]}],"id":[{"id":"10.13039\/501100002631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025\\u201316065287"],"award-info":[{"award-number":["RS-2025\\u201316065287"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cytogfr.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:29:32Z","timestamp":1768004972000},"page":"32-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Reprogramming immunity at the metabolic\u2013epidermal interface in obesity-associated psoriasis"],"prefix":"10.1016","volume":"88","author":[{"given":"Jinsun","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minji","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YunJae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.003_bib1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101306","article-title":"Unveiling multifaceted roles of myeloid innate immune cells in the pathogenesis of psoriasis","volume":"99","author":"Park","year":"2024","journal-title":"Mol. Asp. Med."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.003_bib3","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.jid.2018.03.1509","article-title":"Eosinophils accelerate pathogenesis of psoriasis by supporting an inflammatory milieu that promotes neutrophil infiltration","volume":"138","author":"Kim","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.003_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13679-020-00380-3","article-title":"Deciphering the association between psoriasis and obesity: Current evidence and treatment considerations","volume":"9","author":"Paroutoglou","year":"2020","journal-title":"Curr. Obes. Rep."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1468-3083.2011.04065.x","article-title":"Obesity and psoriasis: body weight and body mass index influence the response to biological treatment","volume":"25","author":"Puig","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib6","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3389\/fimmu.2019.01807","article-title":"Psoriasis: Obesity and fatty acids","volume":"10","author":"Kunz","year":"2019","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.cytogfr.2026.01.003_bib7","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.7150\/thno.116796","article-title":"Systemic inflammation-induced adipose tissue remodeling drives psoriasis exacerbation in obesity through epigenetic and immunometabolic dysregulation","volume":"15","author":"Jang","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jimmun\/vkae011","article-title":"Impact of obesity on the CCR6-CCL20 axis in epidermal \u03b3\u03b4 T cells and IL-17A production in murine wound healing and psoriasis","volume":"214","author":"Lawler","year":"2025","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.003_bib9","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jid.2016.03.002","article-title":"Increased lipocalin-2 contributes to the pathogenesis of psoriasis by modulating neutrophil chemotaxis and cytokine secretion","volume":"136","author":"Shao","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13148-018-0541-9","article-title":"Epigenome-wide DNA methylation regulates cardinal pathological features of psoriasis","volume":"10","author":"Chandra","year":"2018","journal-title":"Clin. Epigenetics"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.003_bib11","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/bjd.12144","article-title":"Oxidative stress and psoriasis: the effect of antitumour necrosis factor-alpha inhibitor treatment","volume":"168","author":"Bacchetti","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.003_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jaad.2024.12.016","article-title":"The association between obesity and efficacy of psoriasis therapies: An expert consensus panel","volume":"92","author":"Burshtein","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000455840","article-title":"Psoriasis and obesity","volume":"232","author":"Jensen","year":"2017","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103577","article-title":"Global prevalence of obesity in patients with psoriasis: An analysis in the past two decades","volume":"23","author":"Wang","year":"2024","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.003_bib15","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.jid.2025.04.013","article-title":"The visceral relationship of psoriasis and obesity","volume":"145","author":"Gelfand","year":"2025","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib16","doi-asserted-by":"crossref","first-page":"1328297","DOI":"10.3389\/fimmu.2024.1328297","article-title":"A genome-wide cross-trait analysis identifies shared loci and causal relationships of obesity and lipidemic traits with psoriasis","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.003_bib17","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1007\/s10067-025-07637-z","article-title":"Prevalence of metabolic syndrome and its components in psoriatic arthritis compared with general population, cutaneous psoriasis, and other inflammatory arthropathies: a meta-analysis","volume":"44","author":"Andreasson","year":"2025","journal-title":"Clin. Rheuma"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/exd.13484","article-title":"High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice","volume":"27","author":"Higashi","year":"2018","journal-title":"Exp. Dermatol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib19","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jid.2018.03.1522","article-title":"High-fat diet exacerbates early psoriatic skin inflammation independent of obesity: Saturated fatty acids as key players","volume":"138","author":"Herbert","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib20","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jid.2018.12.002","article-title":"A western diet, but not a high-fat and low-sugar diet, predisposes mice to enhanced susceptibility to imiquimod-induced psoriasiform dermatitis","volume":"139","author":"Yu","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41392-022-01219-0","article-title":"Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.003_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41577-024-01103-8","article-title":"Adipokines: masterminds of metabolic inflammation","volume":"25","author":"Tilg","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.003_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000481882","article-title":"Serum Leptin, Resistin, and Adiponectin Concentrations in Psoriasis: A Meta-Analysis of Observational Studies","volume":"233","author":"Kyriakou","year":"2017","journal-title":"Dermatology"},{"issue":"6505","key":"10.1016\/j.cytogfr.2026.01.003_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.metabol.2014.09.010","article-title":"Structure, production and signaling of leptin","volume":"64","author":"M\u00fcnzberg","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.cytogfr.2026.01.003_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.622468","article-title":"The role of the adipokine leptin in immune cell function in health and disease","volume":"11","author":"Kiernan","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib27","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.4049\/jimmunol.1004054","article-title":"Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils","volume":"186","author":"Suzukawa","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s10020-023-00702-w","article-title":"Leptin\/obR signaling exacerbates obesity-related neutrophilic airway inflammation through inflammatory M1 macrophages","volume":"29","author":"Wang","year":"2023","journal-title":"Mol. Med."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.003_bib29","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.4049\/jimmunol.1402996","article-title":"Leptin receptor signaling in T cells is required for Th17 differentiation","volume":"194","author":"Reis","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/exd.12162","article-title":"Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro--a possible reason for increased severity of psoriasis in patients with a high body mass index","volume":"22","author":"Xue","year":"2013","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.003_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/JD9.0000000000000353","article-title":"Leptin modulates the differentiation of keratinocytes via autophagy in psoriasis patients with metabolic syndrome","volume":"7","author":"Song","year":"2023","journal-title":"Int. J. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib32","doi-asserted-by":"crossref","first-page":"2309305","DOI":"10.1080\/09546634.2024.2309305","article-title":"Leptin induces altered differentiation of keratinocytes by inducing insulin resistance: implications for metabolic syndrome-induced resistance of psoriatic therapy","volume":"35","author":"Wang","year":"2024","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib33","doi-asserted-by":"crossref","first-page":"1607312","DOI":"10.3389\/fimmu.2025.1607312","article-title":"Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients","volume":"16","author":"Belli","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/08820139.2023.2288836","article-title":"Resistin - A plausible therapeutic target in the pathogenesis of psoriasis","volume":"53","author":"Srikanth","year":"2024","journal-title":"Immunol. Invest"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.003_bib35","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.bbrc.2005.06.202","article-title":"Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway","volume":"334","author":"Silswal","year":"2005","journal-title":"Biochem Biophys. Res Commun."},{"issue":"6b","key":"10.1016\/j.cytogfr.2026.01.003_bib36","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1582-4934.2009.00899.x","article-title":"Resistin competes with lipopolysaccharide for binding to toll-like receptor 4","volume":"14","author":"Tarkowski","year":"2010","journal-title":"J. Cell Mol. Med"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.003_bib37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cmet.2014.01.013","article-title":"Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes","volume":"19","author":"Lee","year":"2014","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib38","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.chom.2019.04.004","article-title":"Resistin-like molecule \u03b1 provides vitamin-A-dependent antimicrobial protection in the skin","volume":"25","author":"Harris","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12944-015-0039-9","article-title":"Increased serum resistin levels correlate with psoriasis: a meta-analysis","volume":"14","author":"Huang","year":"2015","journal-title":"Lipids Health Dis."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.003_bib40","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.apsb.2020.12.008","article-title":"Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib41","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jid.2019.07.727","article-title":"Interaction of resistin and systolic blood pressure in psoriasis severity","volume":"140","author":"Seth","year":"2020","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","article-title":"Adiponectin \u2013 journey from an adipocyte secretory protein to biomarker of the metabolic syndrome","volume":"257","author":"TRUJILLO","year":"2005","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12944-021-01510-z","article-title":"Adiponectin in psoriasis and its comorbidities: a review","volume":"20","author":"Ruiyang","year":"2021","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.003_bib44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/24755303231199995","article-title":"Serum adiponectin levels as an independent marker of severity of psoriasis: A cross-sectional analysis","volume":"8","author":"Kaushik","year":"2023","journal-title":"J. Psoriasis Psoriatic Arthritis"},{"issue":"6941","key":"10.1016\/j.cytogfr.2026.01.003_bib45","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"issue":"7293","key":"10.1016\/j.cytogfr.2026.01.003_bib46","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nature08991","article-title":"Adiponectin and AdipoR1 regulate PGC-1\u03b1 and mitochondria by Ca2+ and AMPK\/SIRT1","volume":"464","author":"Iwabu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2026.01.003_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114568","article-title":"Adiponectin receptor agonist adipoRon alleviates imiquimod-induced murine psoriasis","volume":"154","author":"Sun","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib48","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2147\/JIR.S499835","article-title":"Metabolism-related adipokines and metabolic diseases: their role in osteoarthritis","volume":"18","author":"Zhang","year":"2025","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.cytogfr.2026.01.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112002","article-title":"Lipocalin-2: Structure, function, distribution and role in metabolic disorders","volume":"142","author":"Jaberi","year":"2021","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jamadermatol.2025.0288","article-title":"Association of obesity and innate immune markers with resistance to biologic therapy in psoriasis","volume":"161","author":"Kim","year":"2025","journal-title":"JAMA Dermatol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.003_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/der2.60","article-title":"Evaluation of tissue and serum lipocalin 2 in psoriasis vulgaris and its implications on subclinical atherosclerosis","volume":"2","author":"Hassab-El-Naby","year":"2021","journal-title":"Dermatol. Rev."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.003_bib52","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41423-025-01292-9","article-title":"Synergistic effects of LCN2 and TWEAK on the progression of psoriasis","volume":"22","author":"Ren","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.003_bib53","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"Moschen","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib54","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2133.2012.10980.x","article-title":"Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity","volume":"167","author":"Ismail","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0625.2011.01402.x","article-title":"Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?","volume":"21","author":"Gerdes","year":"2012","journal-title":"Exp. Dermatol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.003_bib56","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jid.2019.02.005","article-title":"Nicotinamide metabolism modulates the proliferation\/differentiation balance and senescence of human primary keratinocytes","volume":"139","author":"Tan","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"13","key":"10.1016\/j.cytogfr.2026.01.003_bib57","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.3390\/ijms22136860","article-title":"Enhanced NAMPT-mediated NAD salvage pathway contributes to psoriasis pathogenesis by amplifying epithelial auto-inflammatory circuits","volume":"22","author":"Mercurio","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2337\/db16-0286","article-title":"Hepatocytes are the principal source of circulating RBP4 in mice","volume":"66","author":"Thompson","year":"2016","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.003_bib59","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1128\/MCB.06193-11","article-title":"Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism","volume":"32","author":"Norseen","year":"2012","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12865-024-00647-7","article-title":"Pre-treatment plasma retinol binding protein 4 level and its change after treatments predict systemic treatment response in psoriasis patients","volume":"25","author":"Niu","year":"2024","journal-title":"BMC Immunol."},{"issue":"6028","key":"10.1016\/j.cytogfr.2026.01.003_bib61","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1126\/science.1199214","article-title":"The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice","volume":"332","author":"Tang","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cmet.2011.12.002","article-title":"PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue","volume":"15","author":"Matsubara","year":"2012","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/imm.12446","article-title":"Progranulin is preferentially expressed in patients with psoriasis vulgaris and protects mice from psoriasis-like skin inflammation","volume":"145","author":"Huang","year":"2015","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.003_bib64","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2174\/1381612823666170124114524","article-title":"Progranulin, a new adipokine at the crossroads of metabolic syndrome, diabetes, dyslipidemia and hypertension","volume":"23","author":"Korolczuk","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib65","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/jocd.12966","article-title":"Progranulin and beta-catenin in psoriasis: An immunohistochemical study","volume":"18","author":"Farag","year":"2019","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.phrs.2019.04.030","article-title":"Osteopontin as a multifaceted driver of bone metastasis and drug resistance","volume":"144","author":"Pang","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.003_bib67","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1172\/JCI31986","article-title":"Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice","volume":"117","author":"Nomiyama","year":"2007","journal-title":"J. Clin. Invest"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib68","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2014.04.013","article-title":"Expression of osteopontin genotypes (T-4754-C and A-9138-C) in psoriasis and their relation to metabolic syndrome","volume":"75","author":"Abdel Hay","year":"2014","journal-title":"J. Dermatol. Sci."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib69","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1600-0625.2009.00926.x","article-title":"Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology","volume":"18","author":"Buback","year":"2009","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib70","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2008.05.008","article-title":"Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin","volume":"29","author":"Shinohara","year":"2008","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.003_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/exd.15185","article-title":"C. Next-Generation ImmunoDermatology, Lesional psoriasis is associated with alterations in the stratum corneum ceramide profile and concomitant decreases in barrier function","volume":"33","author":"Rousel","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.003_bib72","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41366-023-01343-z","article-title":"Investigating causal relationships between obesity and skin barrier function in a multi-ethnic Asian general population cohort","volume":"47","author":"Yew","year":"2023","journal-title":"Int. J. Obes. (Lond. )"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib73","doi-asserted-by":"crossref","first-page":"714","DOI":"10.5114\/ada.2019.91422","article-title":"I. Flisiak, Serum sphingolipid level in psoriatic patients with obesity","volume":"36","author":"Kozlowska","year":"2019","journal-title":"Post. Dermatol. Alergol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120515","article-title":"The role of lipidomics in psoriasis","volume":"578","author":"Boboryko","year":"2026","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cytogfr.2026.01.003_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112704","article-title":"Role of glucose metabolism reprogramming in keratinocytes in the link between psoriasis and metabolic syndrome","volume":"139","author":"Yan","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.003_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/exd.15127","article-title":"Metabolic dynamics in psoriatic epidermis: Enhanced glucose and lactate uptake, glycolytic pathway and TCA cycle dynamics","volume":"33","author":"Nakamizo","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib77","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1038\/s41467-025-63791-7","article-title":"Keratinocyte-specific H4K12 lactylation drives a non-canonical IL-17-dependent signaling in psoriasis progression in mice","volume":"16","author":"Shen","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib78","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41419-024-06706-6","article-title":"FBP1 orchestrates keratinocyte proliferation\/differentiation and suppresses psoriasis through metabolic control of histone acetylation","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib79","article-title":"Exploring the comorbidity mechanisms between psoriasis and obesity based on bioinformatics","volume":"30","author":"Gao","year":"2024","journal-title":"Ski. Res. Technol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.003_bib80","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.003_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113449","article-title":"Keratinocyte FABP5-VCP complex mediates recruitment of neutrophils in psoriasis","volume":"42","author":"Hao","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib82","article-title":"Enhanced migratory ability of neutrophils toward epidermis contributes to the development of psoriasis via crosstalk with keratinocytes by releasing IL-17A","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"31","key":"10.1016\/j.cytogfr.2026.01.003_bib83","doi-asserted-by":"crossref","first-page":"20692","DOI":"10.1074\/jbc.M109.018556","article-title":"Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis","volume":"284","author":"Neels","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib84","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/exd.12691","article-title":"Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice","volume":"24","author":"Kanemaru","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.003_bib85","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1038\/jid.2011.241","article-title":"Dysfunctional gammadelta T cells contribute to impaired keratinocyte homeostasis in mouse models of obesity","volume":"131","author":"Taylor","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib86","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41423-025-01278-7","article-title":"Saturated fatty acid-induced neutrophil extracellular traps contribute to exacerbation and biologic therapy resistance in obesity-related psoriasis","volume":"22","author":"Xia","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.003_bib87","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41366-018-0148-4","article-title":"Inflammation-linked adaptations in dermal microvascular reactivity accompany the development of obesity and type 2 diabetes","volume":"43","author":"Nguyen-Tu","year":"2019","journal-title":"Int. J. Obes. (Lond. )"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib88","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2340\/00015555-2227","article-title":"Insulin resistance may contribute to upregulation of adhesion molecules on endothelial cells in psoriatic plaques","volume":"96","author":"Schluter","year":"2016","journal-title":"Acta Derm. Venereol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160451","article-title":"An IGFBP7hi endothelial cell subset drives T cell extravasation in psoriasis via endothelial glycocalyx degradation","volume":"133","author":"Li","year":"2023","journal-title":"J. Clin. Invest"},{"issue":"2 Pt 2","key":"10.1016\/j.cytogfr.2026.01.003_bib90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jcmg.2017.08.014","article-title":"Visceral adiposity in psoriasis is associated with vascular inflammation by 18F-fluorodeoxyglucose positron-emission tomography\/computed tomography beyond cardiometabolic disease risk factors in an observational cohort study","volume":"11","author":"Rivers","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.cytogfr.2026.01.003_bib91","article-title":"Adipose tissue macrophage-derived PPBP exacerbates psoriasis-associated atherosclerosis by inducing mitochondrial dysfunction in aortic endothelial cells","author":"Zhu","year":"2025","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.003_bib92","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.4049\/jimmunol.1402307","article-title":"Chronic psoriatic skin inflammation leads to increased monocyte adhesion and aggregation","volume":"195","author":"Golden","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.003_bib93","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.7150\/thno.67174","article-title":"Overexpression of S100A9 in obesity impairs macrophage differentiation via TLR4-NFkB-signaling worsening inflammation and wound healing","volume":"12","author":"Franz","year":"2022","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116254","article-title":"FABP5 in skin macrophages mediates saturated fat-induced IL-1beta signaling in psoriatic inflammation","volume":"44","author":"Yu","year":"2025","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2024.02.015","article-title":"Monocyte-to-high-density lipoprotein ratio is associated with systemic inflammation, insulin resistance, and coronary subclinical atherosclerosis in psoriasis: Results from 2 observational cohorts","volume":"144","author":"Berna-Rico","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.916701","article-title":"Metabolic syndrome in psoriasis is associated with upregulation of CXCL16 on monocytes and a dysbalance in innate lymphoid cells","volume":"13","author":"Schielke","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib97","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202345","article-title":"Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis","volume":"218","author":"Nakamizo","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib98","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.imlet.2022.12.002","article-title":"Dendritic cells in energy balance regulation","volume":"253","author":"Redondo-Urzainqui","year":"2023","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/imr.13215","article-title":"Lipid metabolism in dendritic cell biology","volume":"317","author":"You","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fendo.2020.00555","article-title":"Shaping of dendritic cell function by the metabolic micro-environment","volume":"11","author":"Brombacher","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.003_bib101","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/eji.201546263","article-title":"Free fatty acids sensitize dendritic cells to amplify TH1\/TH17-immune responses","volume":"46","author":"Stelzner","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib102","doi-asserted-by":"crossref","first-page":"13581","DOI":"10.1038\/ncomms13581","article-title":"Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation","volume":"7","author":"Singh","year":"2016","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.cytogfr.2026.01.003_bib103","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150223","article-title":"Abnormal lipid metabolism in epidermal Langerhans cells mediates psoriasis-like dermatitis","volume":"7","author":"Zhang","year":"2022","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.003_bib104","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib105","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/eji.200838893","article-title":"Obesity predisposes to Th17 bias","volume":"39","author":"Winer","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14292-1","article-title":"High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing gammadelta T cells","volume":"7","author":"Nakamizo","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.003_bib107","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.immuni.2023.06.021","article-title":"Obesity-induced dysregulation of skin-resident PPARgamma(+) Treg cells promotes IL-17A-mediated psoriatic inflammation","volume":"56","author":"Sivasami","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib108","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12944-025-02615-5","article-title":"Exploring the association between relative fat mass and psoriasis risk: insights from the NHANES data","volume":"24","author":"Chen","year":"2025","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib109","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1016\/j.jid.2025.03.024","article-title":"Investigating the genetic basis of the influence of adiposity on psoriasis: A cross-sectional study in a large United Kingdom population-based biobank","volume":"145","author":"Ramessur","year":"2025","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.003_bib110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41423-025-01296-5","article-title":"Dermal adipogenesis protects against neutrophilic skin inflammation during psoriasis pathogenesis","volume":"22","author":"Xia","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib111","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajhg.2014.12.004","article-title":"Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms","volume":"96","author":"Baurecht","year":"2015","journal-title":"Am. J. Hum. Genet"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.003_bib112","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.3528","article-title":"Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat. Genet"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib113","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13098-022-00947-1","article-title":"Recent progress in epigenetics of obesity","volume":"14","author":"Wu","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib114","article-title":"Integrated multiomic analysis reveals the high-fat diet induced activation of the MAPK signaling and inflammation associated metabolic cascades via histone modification in adipose tissues","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Genet"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaci.2024.05.008","article-title":"Inflammatory memory in psoriasis: From remission to recurrence","volume":"154","author":"Francis","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib116","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13148-016-0297-z","article-title":"Epigenome-wide association data implicates DNA methylation-mediated genetic risk in psoriasis","volume":"8","author":"Zhou","year":"2016","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib117","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13059-014-0570-4","article-title":"Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin","volume":"16","author":"Tsoi","year":"2015","journal-title":"Genome Biol."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.003_bib118","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.118.313608","article-title":"Association between oxidation-modified lipoproteins and coronary plaque in psoriasis","volume":"123","author":"Sorokin","year":"2018","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.003_bib119","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jacl.2018.03.091","article-title":"Identification of proresolving and inflammatory lipid mediators in human psoriasis","volume":"12","author":"Sorokin","year":"2018","journal-title":"J. Clin. Lipido"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamadermatol.2019.3595","article-title":"Association between soluble lectinlike oxidized low-density lipoprotein receptor-1 and coronary artery disease in psoriasis","volume":"156","author":"Dey","year":"2020","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib121","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00403-019-01976-z","article-title":"Plasma oxidation status and antioxidant capacity in psoriatic children","volume":"312","author":"Bacchetti","year":"2020","journal-title":"Arch. Dermatol. Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib122","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/jdv.18631","article-title":"Mitochondrial dysfunction: The pathological link between psoriasis and insulin resistance?","volume":"37","author":"Villarreal-Martinez","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib123","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1111\/jdv.20133","article-title":"Multi-treatment resistance to biological treatment in patients with psoriasis: Definitions and implications","volume":"39","author":"Henckens","year":"2025","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib124","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2018.08.025","article-title":"Differential efficacy of biologic treatments targeting the TNF-\u03b1\/IL-23\/IL-17 axis in psoriasis and psoriatic arthritis","volume":"111","author":"Furue","year":"2018","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.003_bib125","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jamadermatol.2024.1677","article-title":"Clinical characteristics associated with response to biologics in the treatment of psoriasis: A meta-analysis","volume":"160","author":"Hjort","year":"2024","journal-title":"JAMA Dermatol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.003_bib126","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.orcp.2023.05.004","article-title":"Impact of biologic agents on body weight and obesity-related disorders in patients with psoriasis: A nationwide population-based cohort study","volume":"17","author":"Kim","year":"2023","journal-title":"Obes. Res. Clin. Pr."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.003_bib127","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/bjd\/ljae147","article-title":"Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China","volume":"191","author":"Huang","year":"2024","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12895-016-0049-y","article-title":"Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)","volume":"16","author":"Singh","year":"2016","journal-title":"BMC Dermatol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.003_bib129","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/bjd.12735","article-title":"Study, Diet and physical exercise in psoriasis: a randomized controlled trial","volume":"170","author":"Naldi","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.003_bib130","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/acs.jproteome.0c00646","article-title":"Effect of very-low-calorie ketogenic diet on psoriasis patients: A nuclear magnetic resonance-based metabolomic study","volume":"20","author":"Castaldo","year":"2021","journal-title":"J. Proteome Res."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib131","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/jdi.14037","article-title":"Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events","volume":"14","author":"Maezawa","year":"2023","journal-title":"J. Diabetes Invest."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib132","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12944-023-01999-6","article-title":"Serum lipidomic study of long-chain fatty acids in psoriasis patients prior to and after anti-IL-17A monoclonal antibody treatment by quantitative GC-MS analysis with in situ extraction","volume":"23","author":"Guo","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.003_bib133","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/09546634.2020.1826392","article-title":"Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial","volume":"33","author":"Lin","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.003_bib134","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.medcli.2023.05.021","article-title":"Effects of liraglutide among patients living with psoriasis and obesity","volume":"161","author":"Nicolau","year":"2023","journal-title":"Med. Clin. (Barc. )"},{"issue":"32","key":"10.1016\/j.cytogfr.2026.01.003_bib135","article-title":"The efficacy and safety of pioglitazone in psoriasis vulgaris: A meta-analysis of randomized controlled trials","volume":"99","author":"Chen","year":"2020","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.cytogfr.2026.01.003_bib136","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2147\/CCID.S368845","article-title":"Metformin inhibits HaCaT cell proliferation under hyperlipidemia through reducing reactive oxygen species via FOXO3 activation","volume":"15","author":"Zhang","year":"2022","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib137","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41420-020-0245-8","article-title":"Metformin inhibits IL-1beta secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis","volume":"6","author":"Tsuji","year":"2020","journal-title":"Cell Death Discov."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.003_bib138","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.clnu.2013.09.010","article-title":"Energy-restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial","volume":"33","author":"Guida","year":"2014","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib139","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s42000-025-00697-5","article-title":"GLP-1 agonists on a roll: from obesity to psoriasis - an elixir to watch!","volume":"24","author":"Stratakis","year":"2025","journal-title":"Horm. (Athens)"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13578-025-01486-8","article-title":"Roles of glucagon-like peptide 1 receptor agonists in immune cell biology and autoimmune\/autoinflammatory diseases","volume":"15","author":"Deng","year":"2025","journal-title":"Cell Biosci."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.003_bib141","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/09546634.2019.1708853","article-title":"Liraglutide improved inflammation via mediating IL-23\/Th-17 pathway in obese diabetic mice with psoriasiform skin","volume":"32","author":"Chen","year":"2021","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib142","article-title":"Two birds one stone: semaglutide is highly effective against severe psoriasis in a type 2 diabetic patient","volume":"2021","author":"Costanzo","year":"2021","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.003_bib143","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2018-02526","article-title":"Safety of metformin in psoriasis patients with diabetes mellitus: A 17-Year population-based real-world cohort study","volume":"104","author":"Su","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"40","key":"10.1016\/j.cytogfr.2026.01.003_bib144","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp5332","article-title":"N6-methyladenosine modification-tuned lipid metabolism controls skin immune homeostasis via regulating neutrophil chemotaxis","volume":"10","author":"Cui","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.003_bib145","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76864-y","article-title":"Neutrophil extracellular traps are induced in a psoriasis model of interleukin-36 receptor antagonist-deficient mice","volume":"10","author":"Watanabe","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2026.01.003_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156543","article-title":"Jinkui Shenqi decoction targets PAD4 to restrain NETosis and ameliorates psoriasis progression","volume":"139","author":"Zhao","year":"2025","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.003_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100428","article-title":"Eicosapentaenoic acid reduces the proportion of IL-17A-producing T cells in a 3D psoriatic skin model","volume":"64","author":"Morin","year":"2023","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.003_bib148","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3892\/mmr.2014.2136","article-title":"Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17\/IL-23 axis","volume":"9","author":"Qin","year":"2014","journal-title":"Mol. Med Rep."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.003_bib149","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/13813455.2024.2407547","article-title":"Combination therapy of systemic and local metformin improves imiquimod-induced psoriasis-like lesions with type 2 diabetes: the role of AMPK\/KGF\/STAT3 axis","volume":"131","author":"Hassan","year":"2025","journal-title":"Arch. Physiol. Biochem"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:03:45Z","timestamp":1773968625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610126000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":149,"alternative-id":["S1359610126000031"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.01.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming immunity at the metabolic\u2013epidermal interface in obesity-associated psoriasis","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}